Scrip
Market Insight - Why Pfizer has the hots for Wyeth
25 February 2009
Anthony Nealon and Simon King
25 February 2009
Anthony Nealon and Simon King
The Pfizer-Wyeth merger announced on January 26th will create a pharmaceutical company of unprecedented industry scale, with combined total revenues in 2008 exceeding $70 billion and prescription sales of more than $60 billion alone. Pfizer's underlying motive for...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
